KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Cash (2016 - 2025)

Gilead Sciences' Change in Cash history spans 17 years, with the latest figure at $233.0 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 95.3% year-over-year to $233.0 million; the TTM value through Dec 2025 reached -$2.4 billion, down 162.16%, while the annual FY2025 figure was -$2.4 billion, 162.16% down from the prior year.
  • Change in Cash reached $233.0 million in Q4 2025 per GILD's latest filing, down from $2.2 billion in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $5.0 billion in Q4 2024 to a low of -$2.8 billion in Q2 2025.
  • Average Change in Cash over 5 years is $78.3 million, with a median of $117.0 million recorded in 2023.
  • The largest YoY upside for Change in Cash was 226300.0% in 2024 against a maximum downside of 353.39% in 2024.
  • A 5-year view of Change in Cash shows it stood at $976.0 million in 2021, then dropped by 26.95% to $713.0 million in 2022, then plummeted by 46.7% to $380.0 million in 2023, then skyrocketed by 1203.95% to $5.0 billion in 2024, then crashed by 95.3% to $233.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Change in Cash are $233.0 million (Q4 2025), $2.2 billion (Q3 2025), and -$2.8 billion (Q2 2025).